News | Lung Cancer | May 21, 2018

ACR Urges Stricter Adherence to Lung Cancer Screening Guidelines

Association warns that provider ignorance of low-dose CT screening guidelines, lack of physician and patient education, and low Medicare reimbursement result in increased mortality

ACR Urges Stricter Adherence to Lung Cancer Screening Guidelines

May 21, 2018 — A new statement from the American College of Radiology (ACR) asserts that provider non-compliance to lung cancer screening guidelines may be resulting in thousands of unnecessary deaths each year. The statement attributes the phenomenon to physician ignorance of lung cancer screening guidelines, lack of patient and physician education on the benefits of screening, and drastically low Medicare reimbursement for low-dose computed tomography (LDCT) lung cancer screening exams.

More than 220,000 people will be diagnosed with lung cancer in 2018. Nearly 160,000 people will die from the disease — more than from breast, colon and prostate cancers combined. This exam is the first and only cost-effective test proven to significantly reduce lung cancer deaths, according to the ACR.

The United States Preventive Services Task Force (USPSTF) recommends lung cancer screening for high-risk, older current and former smokers. Yet, these exams remain comparatively unused – according to a recent study presented at the American Society of Clinical Oncology (ASCO).

“CT lung cancer screening can save more lives than any cancer screening test in history, but patients are not hearing about this test from their doctors. Medicare is not adequately covering these exams. This noncompliance and practical non-coverage is contributing to unnecessary deaths due to lack of screening,” said Ella Kazerooni, M.D., FACR, chair of the ACR Lung Cancer Screening Committee and ACR Thoracic Imaging Panel.

Updates to Lung-RADS — a quality assurance tool to standardize lung cancer screening CT reporting and management recommendations — has reduced false positive rates by 75 percent compared to previous studies, according to the college. This process will improve, but only with an adequate number of patients to screen and review.

Previous psychological studies show that patient concern over cancer screening false positives is short-term with no lasting effects.

Given the immediate threat to older current and former smokers from this disease, the significant lifesaving benefit of these exams outweighs any likely harms to the defined screening population, the association said. In fact, patients are required by law to be made aware of the harms of screening and other pertinent information prior to any exams being performed.

Unlike breast and colon cancer screening, a patient’s primary care physician must approve the patient to get a lung cancer screening exam during a shared-decision making visit. Many of these providers are unaware of the exams – or not informed on the benefits of these scans.

According to the ASCO study, 12,000 people per year may be dying due to lack of screening. Many of these people may never hear that there is a test that can help save them. Additional education of both ordering physicians and patients, such as “Saved by the Scan,” is necessary.

Shortly after providing coverage for these exams, the Centers for Medicare & Medicaid Services slashed Medicare reimbursement to approximately $60 per exam. That is less than half the Medicare provider reimbursement for a mammogram. Such cuts have largely restricted the number of facilities financially able to provide these scans to large teaching hospitals. The ACR said funding for lung cancer screening exams needs to be greatly increased.

The medical community is working to maximize the lifesaving benefits of these tests, by reducing false positive exams and restricting screening to populations most likely to benefit from screening. However, the ACR said Medicare needs to provide realistic coverage for these tests. These processes can occur at the same time.

“Thousands of people each year should not be allowed to die needlessly while the medical community fine tunes the only exam proven to save lives from the nation’s leading cancer killer. Medicare must also provide adequate reimbursement. We need to save lives now,” said Kazerooni.

For more information: www.radiologyinfo.org

Related Content

Johns Hopkins Medicine First in U.S. to Install Canon Medical's Aquilion Precision
News | Computed Tomography (CT) | March 26, 2019
March 26, 2019 — Johns Hopkins Medicine now has access to the first...
At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve).

At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve). Photo by Greg Freiherr

Feature | Cardiac Imaging | March 22, 2019 | By Greg Freiherr
Reflecting a trend toward the increased use of...
Researchers Use Radiomics to Predict Who Will Benefit from Chemotherapy
News | Radiomics | March 21, 2019
Using data from computed tomography (CT) images, researchers may be able to predict which lung cancer patients will...
Older Biologic Age Linked to Elevated Breast Cancer Risk
News | Women's Health | March 19, 2019
Biologic age, a DNA-based estimate of a person’s age, is associated with future development of breast cancer, according...
HeartFlow Analysis Successfully Stratifies Heart Disease Patients at One Year
News | CT Angiography (CTA) | March 19, 2019
Late-breaking results confirm the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis enables...
Podcast | Cardiac Imaging | March 15, 2019
Debate About Coronary Testing Highlights ACC Session
Canon Medical Introduces Entry-Level Aquilion Start CT
News | Computed Tomography (CT) | March 14, 2019
Canon Medical Systems Europe B.V. introduced the all-new Aquilion Start computed tomography (CT) system to the European...
Hologic Receives CE Mark for Three-in-One Omni Hysteroscope
News | Endoscopes | March 14, 2019
Hologic Inc. announced it has received a CE mark in Europe for its Omni hysteroscope, a three-in-one modular scope with...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...
Siemens Healthineers Debuts Cardiovascular Edition of Somatom go.Top CT
News | Computed Tomography (CT) | March 14, 2019
Siemens Healthineers will introduce the Somatom go.Top Cardiovascular Edition, a new version of its established...